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Abstract
Background: Admission to the neonatal intensive care unit (NICU) may disrupt parent-infant interaction with
adverse consequences for infants and their families. Several family-centered care programs promote parent-infant
interaction in the NICU; however, all of these retain the premise that health-care professionals should provide most of
the infant’s care. Parents play a mainly supportive role in the NICU and continue to feel anxious and unprepared to
care for their infant after discharge. In the Family Integrated Care (FICare) model, parents provide all except the
most advanced medical care for their infants with support from the medical team. Our hypothesis is that infants
whose families complete the FICare program will have greater weight gain and better clinical and parental outcomes
compared with infants provided with standard NICU care.
Methods/Design: FICare is being evaluated in a cluster randomized controlled trial among infants born at ≤ 33 weeks’
gestation admitted to 19 Canadian, 6 Australian, and 1 New Zealand tertiary-level NICU. Trial enrollment began in April,
2013, with a target sample size of 675 infants in each arm, to be completed by August, 2015. Participating sites were
stratified by country, and by NICU size within Canada, for randomization to either the FICare intervention or control
arm. In intervention sites, parents are taught how to provide most of their infant’s care and supported by nursing staff,
veteran parents, a program coordinator, and education sessions. In control sites standard NICU care is provided. The
primary outcome is infants’ weight gain at 21 days after enrollment, which will be compared between the FICare and
control groups using Student’s t-test adjusted for site-level clustering, and multi-level hierarchical models accounting
for both clustering and potential confounders. Similar analyses will examine secondary outcomes including breastfeeding,
clinical outcomes, safety, parental stress and anxiety, and resource use. The trial was designed, is being conducted, and
will be reported according to the CONSORT 2010 guidelines for cluster randomized controlled trials.
Discussion: By evaluating the impact of integrating parents into the care of their infant in the NICU, this trial may
transform the delivery of neonatal care.
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In the highly technological environment of the neonatal
intensive care unit (NICU), infants are physically, psycho-
logically, and emotionally separated from their parents.
Recognition that this experience impedes parent-infant
interaction and is detrimental to the infant, led to the
development of programs such as family-centered care,
kangaroo care, and skin-to-skin care [1–3]. However,
these programs are based on the common premise that
only NICU professionals with special skills can provide
the majority of care for the infant. Parents remain rele-
gated to a supportive role, and some have described
themselves as voyeurs who are “allowed” to visit and
hold their infants [4, 5]. Many feel anxious and unpre-
pared to care for their infants after discharge [6, 7].
This is in stark contrast to the regular nursery, where
care is provided by parents from birth.
In 1979, a shortage of NICU nurses in Estonia prompted
Levin [8, 9] to implement a “humane” care model in which
parents provide nursing care for the infant (except for
respiratory care and administration of intravenous [IV]
fluid and medication), while nurses provide teaching
and guidance to parents. In a non-randomised, before-
after comparison, this model was associated with a
37 % improvement in weight gain in the first 20 days of
life [9]. This study contributed to the growing body of
evidence suggesting that hospitalized infants may thrive
best in a quiet environment, with good nutrition, and
consistent love and care from their parents, but without
excessive stimulation and handling [6, 10, 11]. As first
proposed by Bowlby in 1951 [12], the quality and quan-
tity of the interaction between infants and their parents
is particularly important to this concept. During the
acute phase of NICU care, a variety of studies have re-
ported that maternal presence, specifically through stimuli
provided by voice and breast milk odor, results in more
stable physiological responses [13, 14], improved oral
feeding [15–18], fewer critical events [13, 19], and shorter
length of stay [17, 18] for preterm infants. In the longer
term, strong, responsive parent-infant interaction has been
associated with improved behavioural outcomes in pre-
term infants [20–22], a relationship that may be inhibited
by poor parental mental well-being [23–26]. As such, en-
couraging parental presence in the NICU, and providing
parents with education and support to reduce their stress
levels and improve their knowledge and confidence, is es-
sential to improve preterm infant outcomes.
Building on the evidence from the literature and direct
observation of the program in Estonia, we developed the
Family Integrated Care (FICare) model specifically for the
current Canadian NICU environment, to completely inte-
grate parents into the NICU care team. The principle of
FICare is that in the NICU, families should be supported,
educated, and empowered to provide as much of their
infant’s care as they are able [27, 28]. The FICare pro-
gram includes a parent education program [29], a nurs-
ing education program [30], peer-to-peer support from
‘veteran’ parents [31], and adaptation of the unit pol-
icies, procedures, and other infrastructure as necessary,
to provide social, psychological, and physical supports
that enable greater parent participation.
In a pilot study of the FICare program conducted at
Mount Sinai Hospital, Toronto, 31 FICare infants were
matched 1:2 with control infants (n = 62) based on gen-
der, gestational age (± 2 weeks), birth weight (± 300
grams), age at enrollment, and length of stay following
enrollment of ≥ 21 days. The rate of change in weight
gain was significantly higher in FICare infants compared
with control infants (p < 0.05). There was also a signifi-
cant increase in the rate of breastfeeding at discharge
(82.1 vs. 45.5 %, p < 0.05). The mean Parental Stress
Scale: NICU (PSS:NICU [32]) score for FICare mothers
was 3.06 ± 0.12 at enrolment, which decreased signifi-
cantly to 2.30 ± 0.13 at discharge (p < 0.05) compared
with control mothers, whose stress scores were not sig-
nificantly reduced (3.25 ± 0.19 at admission, 2.99 ± 0.2
on discharge, p > 0.05). Feedback regarding program
implementation from the parents and nurses was very
positive [33].
Hypothesis
The FICare pilot study suggested that the model is feas-
ible and safe in a Canadian healthcare setting, and may
decrease parental stress and improve infant weight gain
as well as other neonatal outcomes. To evaluate the im-
pact of FICare on neonatal and parental outcomes, we
designed and initiated a multi-national, multi-center
cluster randomized controlled trial. Our hypothesis is
that infants whose families complete the FICare inter-
vention will have improved weight gain and better clin-
ical outcomes compared with infants who received




Due to the nature of the intervention, which involves
changes to unit-level provision of care and interaction
between participants, blinding of participants or NICU
staff is not possible. Therefore, to avoid contamination
of patients in the control arm, the cluster randomized
controlled trial design was selected, in which level 3
NICUs were randomized but the intervention was tar-
geted and the outcomes measured at the individual level.
Presently, our prospective multi-centre cluster random-
ized controlled trial is being conducted at 19 tertiary
level Canadian, 6 Australian, and 1 New Zealand NICU.
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The trial was designed, is being conducted, and will be
reported according to the CONSORT 2010 guidelines
for cluster randomized controlled trials [34]. Mount
Sinai Hospital, where the pilot study of FICare was con-
ducted, was assigned a priori to the intervention arm.
Randomization was stratified by country, and within
Canada was stratified by NICU size according to the num-
ber of yearly eligible admissions: < 200 (10 Canadian sites)
or ≥ 200 (9 Canadian sites) admissions. Randomization of
sites was performed using a random number generator.
Enrollment in the trial commenced on 1st April, 2013
and will continue until the required sample size of 675
infants in each arm is reached, which is estimated to
occur in August, 2015.
Study participants
Eligible study infants include those who are: i) born
at ≤ 33 weeks’ gestation; and ii) on no respiratory support
or on low-level respiratory support (i.e., oxygen by can-
nula or mask, or non-invasive ventilation such as continu-
ous positive airway pressure [CPAP], biphasic CPAP and
nasal intermittent positive pressure ventilation). As most
infants born at ≤ 33 weeks’ gestation are not discharged
home until at least 36 weeks’ postmenstrual age, a mini-
mum “dose” of 3 weeks of in-hospital intervention is en-
sured. An additional inclusion criterion at the intervention
sites is that the primary caregiver parent must commit to
spending a minimum of 6 h per day with her/his infant be-
tween the hours of 7 am and 8 pm to enable attendance at
medical rounds and education sessions.
Infants excluded from the study are those who: i) are re-
ceiving palliative care; ii) have a major life-threatening
congenital anomaly; iii) have a critical illness and are un-
likely to survive; iv) are on a high level of respiratory sup-
port (mechanical ventilation, high-frequency oscillatory or
jet ventilation, extra-corporeal membrane oxygenation); v)
are scheduled for early transfer to another hospital; or vi)
have parents with an inability to participate (e.g., health,
family, social, or language issues that might inhibit their
ability to integrate with the health-care team).
Enrollment
Parental consent is being obtained from families of eli-
gible infants at both the intervention and control sites.
For NICUs randomized to the FICare intervention arm,
the site program coordinator approaches parents of all
potentially eligible infants soon after admission to the
NICU to explain the study verbally and deliver an infor-
mation leaflet detailing the purpose and process of the
study, as well as any possible detrimental effects of par-
ticipation. Parents are screened to determine if there
are barriers to their participation in the trial, and in-
formed of the FICare education sessions, which they
may attend regardless of whether they participate in the
trial. Parents are then approached for informed consent
when their baby becomes eligible (i.e., stable on CPAP).
Families are enrolled in the trial, after consent is ob-
tained (Day 0). All families approached are recorded in
a patient eligibility log regardless of actual participation.
Infants whose parents decline to participate in the
study receive standard care at that site.
For NICUs randomized to the control arm, the site pro-
gram coordinator approaches the parents of all potentially
eligible infants for consent to collect infant data and infor-
mation on parental stress and anxiety. The families of eli-
gible infants at control sites are not screened to determine
whether they would be willing to spend at least 6 h per
day in the NICU as per the FICare protocol. The infants
of parents who consent are enrolled in the study once they
meet the inclusion criteria, and continue to receive stand-
ard care.
Participating sites and research ethics approval
Ethics approval for the trial was obtained from the re-
search ethics boards (REBs) of each of the following
participating hospitals: Centre Hospitalier Universitaire
de Quebec-Laval (Comité d’éthique de la recherche du
CHU de Québec), Centre Hospitalier Universitaire de
Sherbrooke (Comité d’éthique de la recherche en santé
chez l'humain du CHUS), Children’s & Women’s Health
Centre of BC (UBC C&W REB), Foothills Medical Centre
(Conjoint Health REB), Hamilton Health Sciences Centre
(Hamilton Integrated REBd), IWK Health Centre (IWK-
REB), Janeway Children’s Health Centre (Health Research
Ethics Authority), Kingston General Hospital (Queen’s
University Health Sciences and Affiliated Teaching Hospi-
tals REB), London Health Sciences Centre (University of
Western Ontario REB for Health Sciences Research In-
volving Human Subjects), Moncton Hospital (Horizon
Health Network REB), Mount Sinai Hospital (Mount
Sinai Hospital REB), Regina General Hospital (Regina
Qu’Appelle Health Region REB), Royal University Hospital
(University of Saskatchewan Biomedical REB), Saint John
Regional Hospital (Horizon Health Network REB), St.
Boniface General Hospital and Health Sciences Centre
Winnipeg (University of Manitoba Health REB), Sunny-
brook Health Sciences Centre (Sunnybrook REB), The
Hospital for Sick Children (SickKids REB), Victoria
General Hospital (UVic/VIHA Joint Research Ethics
Sub-Committee), Windsor Regional Hospital (Windsor
Regional Hospital REB), The Canberra Hospital (ACT
Health Human Research Ethics Committee), Dunedin
Hospital (Central Health and Disability Ethics Commit-
tee), Gold Coast Hospital (South Eastern Sydney Local
Health District Human Research Ethics Committee),
Liverpool Health Service (South Western Sydney Local
Health District Research and Ethics Office), Royal Hos-
pital for Women (South Eastern Sydney Local Health
O’Brien et al. BMC Pediatrics  (2015) 15:210 Page 3 of 9
District Human Research Ethics Committee), Royal North
Shore Hospital Women (South Eastern Sydney Local
Health District Human Research Ethics Committee), and
The Townsville Hospital (The Townsville Hospital Human
Research Ethics Committee).
Privacy and confidentiality
All data are collected on a regular basis throughout the
duration of the trial according to standardized definitions.
The de-identified data are transferred to the CNN Coordin-
ating Centre at the Maternal-Infant Care Research Centre,
Toronto for analysis. All data access and use complies with
the Health Information Act and the Personal Information
Protection and Electronic Documents Act (PIPEDA) in
Canada, the Privacy Act 1988 Sections 95 and 95A in
Australia, and the Privacy Act 1993 and Health Information
Privacy Code in New Zealand. Data security is compliant
with standards established by the CNN and the Mount
Sinai Hospital Research Ethics Board. Only de-identified
information will be used in the analysis and publication of
results. Publications will only use aggregate data.
Patient withdrawals
Parents can withdraw themselves from the study at any
time on their own request. If at any time it is identified that
a parent is having difficulty taking on their new role or is
feeling very stressed, the physician taking care of the infant
will meet with the parent to see what additional supports
are needed. Parents also have access to peer-to-peer sup-
port from veteran parents, social work support, and psychi-
atric consultation on an as-needed basis. If it is felt by the
care team that it is not in the parent’s best interest to con-
tinue with the FICare model of care, this will be discussed
with the parent and other options explored. If there is any
identified risk to the infant by the parent’s continued par-
ticipation, standard care will be applied. If an infant’s med-
ical condition deteriorates such that he/she needs
ventilation, or can no longer be provided adequate medical
care in this model, the family’s involvement will be modified
until the infant’s condition improves and they can resume
full involvement.
Intervention
Enrolled parents are oriented to the unit by a specially
trained FICare program coordinator, who guides the parents
in accessing the tools necessary for their self-education, and
provides information on the charting/diary entries required
and how they will be asked to assume responsibility for
more of their infant’s care. Parents are expected to attend
daily medical rounds, do basic infant charting, and maintain
a diary to the best of their ability with the aim of providing
them with greater knowledge of their infant’s medical status.
Nursing support enables parents to provide care for their
infant(s) through activities such as feeding, bathing,
dressing, and holding skin to skin. Additional support,
particularly around coping within the NICU, is provided to
the parents by volunteer veteran parents [35] and through
special education sessions (see ‘Parent education program’
below).
Resources
Resources are provided to facilitate parents’ ability to spend
as much time as possible at the intervention sites. Each unit
provides a lounge and sleep room for the exclusive use of
parents, as well as amenities to facilitate parents spending
extended periods of time in the hospital. Comfortable
reclining chairs are provided in the NICU for parents to
provide kangaroo and skin-to-skin care, while still being
able to interact with other parents and staff, and breast
pumps are available to facilitate breast feeding. Parents are
also provided with subsidized parking or public transport
vouchers.
Provider/nurse and parent volunteer education program
All doctors, nurses, respiratory therapists, social workers,
and veteran parent volunteers at NICUs in the intervention
arm have been trained in FICare. A team consisting of a
neonatologist and the FICare program coordinator from
each Canadian NICU attended a 2-day training program in
Toronto. The training of the Australian units were
conducted by the Toronto group in Sydney, Australia, while
material from the Toronto group was used to construct a
training workshop for the New Zealand unit in Dunedin,
New Zealand. Training was provided by a multi-disciplinary
team (neonatologist, nurse, psychologist, social worker,
veteran parent volunteer) from Mount Sinai Hospital with
experience in training staff gained during the pilot study.
The training program was designed to provide the skills
needed to teach other staff the concepts of FICare,
including improving parent-infant interaction, re-
conceptualization of the nursing role, coaching skills,
psychological implications of preterm birth on parents,
infant development, and discussions about life as a
FICare nurse and a day in the life of a NICU parent [30].
Following this workshop, each NICU team organised
training for their nursing staff, equivalent to a 4-h training
workshop. Veteran parent volunteers were also orientated
and trained within their own hospitals. Physicians and other
health professionals were trained through presentations at
existing staff meetings, rounds, and journal club-style
forums.
Parent education program
Parent education sessions At the intervention sites, a
parent education program is provided with small group ses-
sions three to five times per week. These sessions provide
parents with information about the medical care of preterm
infants, preterm newborn development, coping within the
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NICU, preparation for discharge, and how they can interact
with their infant more effectively [29]. The sessions follow
a three-week schedule but the content and timing of the
sessions are adapted to the enrolled families’ needs. The
sessions are led by the FICare program coordinator or a
healthcare professional with expertise in the topic being
discussed (e.g., lactation consultant, dietician, pharmacist,
respiratory therapist, mental-health professional). Appro-
priate educational materials including handouts and refer-
ence material may also be provided. Information provided
in the education sessions is reinforced at the bedside by
nursing staff.
Parent checklist Parents are also provided with a skills
checklist to guide them and help them track their education
and skill development. The checklist is used to evaluate
parents’ progress throughout the program and make appro-
priate changes to the support provided as required.
Charting Parents are expected to complete a chart for
their infant on a daily basis including recording the infant’s
activity, feeds, and output. They are also encouraged to
keep a diary, which facilitates parental recall of special
events with their infant. Both the parental chart and diary
are used for communication during medical rounds, but
are not part of the official medical record. Parents record
their time spent at the bedside, performance of skin-to-skin
care, and attendance at the education sessions. The primary
nurse for each infant continues to complete the official
medical record as per hospital protocol.
Psychosocial support
Parent-to-parent support plays a large role in the FICare
model of care. The physical clustering of FICare families to-
gether in the NICU and their participation in small group
education sessions facilitate interaction and sharing of
experiences. Volunteer veteran parents, who have had prior
experience of having an infant admitted to the NICU, visit
each NICU, organize recreational activities, and provide
telephone support for families. This peer-to-peer support
system aims to develop a sense of community among the
FICare families [31]. Additional supports such as social
work and psychiatric consultation are provided on an as-
needed basis.
Data collection
Data collection at both the intervention and control sites
commences at enrollment and continues for the trial dur-
ation (21 days) and through to discharge from the NICU.
Data collection utilizes the existing CNN database platform
[36] in Canada, and in Australia and New Zealand, the
Australian and New Zealand Neonatal Network
(ANZNN) data system [37]. Data collected include demo-
graphics, antenatal and obstetric risks, delivery
complications, admission illness severity scores, and se-
lected practices and outcomes related to this trial. At each
site, a trained research assistant abstracts data daily from
patient charts directly into a laptop computer using a cus-
tomized data entry program with built-in error checking
and a standard manual of definitions. SSL-encrypted data
are electronically transmitted directly from the Canadian
sites to the CNN Coordinating Centre for verification and
further cleaning. The Australia and New Zealand sites
collate data via the ANZNN data verification system and
submit encrypted data in batches to the CNN Coordinat-
ing Center.
Questionnaires and surveys are administered to parents
by site program coordinators, and are available online and
on paper. Data entered into online surveys are automatic-
ally included in a survey database and answers from paper
documents are entered into the database by the program
coordinator. In addition, in the Australia and New Zealand
sites parents have the preferred option of entering answers
directly via smartphone to a purpose-built web-based data-
set that is being collated at the ANZNN Coordinating
Centre.
Outcomes and measures
The primary outcome of the trial is weight gain at
21 days since enrollment in the program, as measured
by the z-score [38]. The z-score refers to the exact num-
ber of standard deviations greater or smaller than the
median, and is used to monitor the growth of the infant
relative to the expected intrauterine growth rate. It is
standardized to population growth standards and super-
ior to percentiles for infants whose size is outside of the
normal range of a growth chart. As part of standard NICU
practice infants are weighed at the same time each day
with their diaper removed. Many infants are weighed on
special scales built into their incubator. To decrease any
risk of measurement bias nurses/parents are asked to first
recalibrate the scales, then weigh the infant three times,
and take the average weight. The bedside nurse charts the
infant’s weight as per usual practice.
The secondary outcomes are: i) weight gain velocity at
21 days since enrollment and weight gain velocity from
birth to 36 weeks corrected gestational age; ii) parent
stress and anxiety; iii) breastfeeding rate at hospital
discharge; iv) clinical outcomes including NICU mortal-
ity and major neonatal morbidities; v) safety as indicated
by the number of critical incident reports per 1000
patient days; and vi) resource use including duration of
oxygen therapy, duration of hospital stay, and potential
cost savings due to reduced length of stay estimated
using per diem costs [39].
The major neonatal morbidities include ≥ stage 2 necro-
tizing enterocolitis (NEC) defined according to Bell’s
criteria [40]; bronchopulmonary dysplasia (BPD) defined
O’Brien et al. BMC Pediatrics  (2015) 15:210 Page 5 of 9
as oxygen dependency at 36 weeks postmenstrual age or
at the time of transfer to a level 2 centre [41]; nosocomial
infection (NI) defined using the Center for Disease Con-
trol criteria [42]; ≥ stage 3 retinopathy of prematurity
(ROP) classified according to the International Classifica-
tion [43]; and ≥ grade 3 intraventricular hemorrhage
(IVH) defined according to the criteria of Papile et al. [44]
from cranial ultrasound during the first 28 days of life.
In both the intervention and control sites, parental
stress and anxiety are measured using questionnaires
(PSS:NICU and the State Trait Anxiety Index [STAI])
administered to parents at enrollment (Day 0) and
Day 21 following enrollment. The PSS:NICU is a vali-
dated instrument to measure parents’ perceptions of
stress within the NICU [32]. It comprises a 46-item
self-report instrument that consists of four subscales
that measure stress related to the: a) sights and
sounds of the unit, b) appearance and behaviour of
the infant, c) impact of the parents’ role and their
relationship with their infant, and d) parents’ relationship
and communication with the staff. The STAI is the defini-
tive instrument for measuring anxiety in adults [45]. It is
well validated, simple to use, and available in 40 languages.
The STAI Form Y comprises of 40 items that can be com-
pleted in about 10 min, and measures state and trait
anxiety. It provides a measure of the severity of the overall
anxiety level.
Sample size calculation
The proposed sample size of 675 infants in each arm of
the trial was estimated for the primary outcome of
weight gain at 21 days post-enrollment, as measured by
the change in z-score (z-score at Day 21 – z-score at en-
rollment), using preliminary data from the FICare pilot
study available at the time of trial design. These data in-
cluded 20 infants in the FICare group with mean change
in z-scores of 0.58 (standard deviation of 0.57), and 40
matched controls with mean change in z-scores of 0.42
(standard deviation of 0.43). Based on this result (38 %
increase in mean z-score change) and Levin’s study [9],
we anticipated at least a 25 % increase in mean z-score
change in the FICare group. The sample size was esti-
mated assuming the above standard deviation estimates
from the preliminary data, and using Kerry’s method
[46, 47] for unequal cluster sizes, given that 16 sites (6
large with average size of 315 eligible infants per year,
and 10 small with average size of 113 eligible infants per
year) had agreed to participate in the trial at that time.
The sample size of 675 infants per arm has 80 % power
to detect a ≥ 25 % difference (absolute difference of 0.11)
in z-score change assuming a significance level of 0.05,
intra-cluster correlation coefficient (ICC) of 0.01 [48, 49],
and a 10 % drop-out rate.
The estimated sample size is feasible to achieve given
that approximately 3200 eligible infants are admitted
each year to the 16 sites committed at the time of trial
design. We also note that statistical power and the
number of eligible infants has been increased by re-
cruitment of additional sites; in total 19 Canadian sites
(10 large sites and 9 small sites) and 7 Australian/New
Zealand sites (all small) have been randomized and ap-
proximately 4300 infants are eligible for enrollment
annually.
Statistical analysis
The unit of analysis will be the individual infant, and all
analyses will be based on the intention to treat principle.
The distribution of baseline characteristics in the study
population will be summarized at the individual and
cluster level within each FICare and control groups,
using descriptive statistical methods. The primary out-
come of weight gain at 21 days post enrollment, will be
compared between the FICare and control groups using
Student’s t-test adjusted for the inflation factor (or de-
sign effect) with a minimum variation weight correction
[46, 47] to account for intra-cluster correlation and im-
balance of cluster sizes. In addition, a two-level hierarch-
ical linear regression model will examine the primary
outcome, accounting for clustering, and potential con-
founders including patient-level characteristics (birth
weight, gestational age, small for gestational age, gen-
der, multiple births, admission illness severity, caesarean
section, chorioamnionitis, maternal hypertension or dia-
betes, maternal education, parity) and NICU-level covari-
ates (NICU size, teaching institution).
Secondary outcomes will be compared between the
FICare and control groups using similar methods in-
cluding the Student’s t-test for continuous variables and
the Chi-square test for categorical variables adjusted for
clustering [50, 51], as well as hierarchical linear or lo-
gistic regression models, as appropriate. Furthermore,
weight change over time will be examined longitudin-
ally using multivariable multi-level hierarchical models
to compare the rate of change in weight gain between
infants from the two trial arms.
While we realize that multiple comparisons are a con-
cern when more than one analysis of the data is per-
formed, we are not interested in the joint confidence
region for all of our hypotheses at once. Rather, we are in-
terested in them one at a time. Under these conditions,
Rothman and Greenland [52, 53] argue that “multiple in-
ference procedures … are irrelevant, inappropriate and
wasteful of information” because they produce improperly
imprecise single intervals.
Prior to data unmasking and analyses, issues relating
to missing data and potential sources of bias will be ex-
amined and appropriate correction methods determined.
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Limitations and feasibility
A cluster randomized trial design was selected to evalu-
ate FICare as it is an organizational and behaviour inter-
vention where blinding of participants or investigators is
not possible. Cluster randomized controlled trials are
more effective at preventing contamination, but more
susceptible to biases than trials randomizing individual
subjects [54, 55]. In this trial, possible allocation bias is
being minimized by the use of appropriate study design
methods for cluster randomization including stratifica-
tion (sites within each country randomized separately;
big and small sites in Canada randomized separately)
with randomization performed using a random number
generator.
Selection bias may arise due to prospective recruit-
ment of families after randomization of NICU sites, and
differences in the nature and process of obtaining in-
formed consent. Study coordinators who recruit families
are not blinded to their site’s allocation and families con-
sent to participate in rather than be randomized to the
FICare intervention or control protocol. At intervention
sites, consent is given to participate in the FICare pro-
gram and to complete study questionnaires and collect
infant data, whereas, at control sites consent is given for
questionnaire completion and data collection only. Not-
ably, the inclusion criteria at FICare sites require a time
commitment of ≥ 6 h, whereas families at control sites
are not specifically asked if they would be able to make
the same commitment. As such, participants at interven-
tion sites who commit to FICare may differ from those at
the control sites, who do not have to commit to spending
extended time in the NICU. For example, families who en-
roll in FICare may be at a higher socioeconomic level or
have greater family support than control families.
To assess selection bias, differences in the enrolment
rate at FICare and control sites will be examined. Multi-
variable analyses will correct possible confounding bias
by adjusting for baseline factors including social, eco-
nomic (parental education, employment), demographic
(maternal age, family size), obstetric (parity, pregnancy
complications) and infant factors (gestational age, small
for gestational age, illness severity at admission, and age
at enrollment). Further analyses will consider propensity
score methods accounting for imbalance of baseline
characteristics between FICare and control groups [54].
While we will attempt to identify and adjust for all the
possible confounding variables, we also acknowledge
that any selection/participation bias could be due to
some unmeasured element of “parent engagement” at
the initiation of the intervention.
Subject attrition may also produce biased results and im-
pact generalizability. Families in the FICare group are pro-
vided with as much physical, psychological and financial
support as possible (including parent lounge; subsidized
parking or a transit pass; access to peer-to-peer, social, and
psychiatric support services), but no such supports are
available to control families. Attrition bias will be mini-
mized by performing statistical analyses according to the
intention to treat principle. To minimize losses due to
retro transfer from level 3 to level 2 units prior to comple-
tion of the 21-day trial period, the original study protocol
has been amended to allow follow-up of these infants
within level 2 units provided these units obtain Research
Ethics Board approval, receive appropriate training, and
comply with the study protocol including providing nurse
education and parent education programs.
Possible bias due to differential withdrawal or study
drop-out will be assessed by examining the distribution
of baseline factors between families who consent and
complete the study, and eligible families who consent
and start but do not complete the study within the
intervention and control sites. Furthermore, a sensitiv-
ity analysis will compare results from complete-case
data and from all families who were enrolled where
missing data are imputed using methods that account
for clustering [56, 57].
Recognizing the limitations of the cluster random-
ized controlled trial design, we have planned to thor-
oughly examine factors that may confound the effect of
FICare with infant and parental outcomes, to correct
analyses for bias when feasible, and to report possible
residual bias.
Discussion
In this age of accountability, infant outcomes, parental
mental health, and reduction of health care costs are im-
portant objectives. The FICare program addresses all
these issues because it can potentially improve infant
outcomes, decrease parental stress and anxiety, and re-
duce resource use including duration of oxygen therapy
and length of hospital stay with potential per diem cost
savings. Improvement of neonatal outcomes by FICare
may lead to reduced mortality and morbidity post-NICU
discharge. In addition, FICare aims to increase the confi-
dence and capability of parents to care for fragile pre-
term infants when they go home, which may reduce the
need for post-discharge support for families, outpatient
clinic visits, re-hospitalizations, and other health care
utilization. Future studies are required to examine the
longer-term effects of FICare. Additional trials may be
conducted to assess the feasibility, safety, and efficacy of
expanding the FICare model of care to NICU infants
who are more acutely ill, such as those on a mechanical
ventilator or who require surgery. If effective, the FICare
model could represent a paradigm shift in approach to
health care that may be applicable to other areas such as
pediatrics, palliative care, geriatrics and chronic care.
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